Literature DB >> 28340952

Lack of association of mortalin (HSPA9) and other mitochondria-related genes with risk of Parkinson's and Alzheimer's diseases.

Sun Ju Chung1, Mi-Jung Kim2, Ho-Sung Ryu3, Juyeon Kim4, Young Jin Kim3, Kiju Kim3, Sooyeoun You5, Seong Yoon Kim6, Jae-Hong Lee3.   

Abstract

We investigated the role of mortalin (HSPA9) and its interaction with other mitochondria-related genes (parkin, PINK1, DJ1, and COQ2) as a risk factor for Parkinson's disease (PD) and Alzheimer's disease (AD) in 500 PD, 400 AD, and 500 control subjects. The HSPA9 variants identified by direct sequencing or its interaction with other genes assessed by genetic risk scores did not show a significant association with PD or AD risk. Our findings did not provide a strong evidence for the role of HAPA9 and its interaction with other mitochondria-related genes as a genetic risk factor for PD or AD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Genetic variation; Mitochondria; Parkinson's disease

Mesh:

Substances:

Year:  2016        PMID: 28340952     DOI: 10.1016/j.neurobiolaging.2016.09.017

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  4 in total

Review 1.  Mitochondrial chaperones in human health and disease.

Authors:  Tyler Bahr; Joshua Katuri; Ting Liang; Yidong Bai
Journal:  Free Radic Biol Med       Date:  2021-11-12       Impact factor: 7.376

Review 2.  Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease.

Authors:  Sandra Franco-Iborra; Miquel Vila; Celine Perier
Journal:  Front Neurosci       Date:  2018-05-23       Impact factor: 4.677

Review 3.  Mortalin/Hspa9 involvement and therapeutic perspective in Parkinson's disease.

Authors:  Baptiste Texier; Morgane Prime; Djamaa Atamena; Pascale Belenguer; Marion Szelechowski
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

4.  Novel role of mortalin in attenuating HIV-1 Tat-mediated astrogliosis.

Authors:  Renu Wadhwa; Rituparna Chaudhuri; Tapas Chandra Nag; Pankaj Seth
Journal:  J Neuroinflammation       Date:  2020-09-20       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.